NATURE . COM {}

Matching Content Categories {📚}

• Science
• Education
• Social Networks

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🚀🌠 Tremendous Traffic: 10M - 20M visitors per month


Based on our best estimate, this website will receive around 16,942,715 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}

Display Ads {🎯}

The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)

google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)

conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}

Display Ads {🎯}

$213,500 per month
Our estimates place Nature.com's monthly online earnings from display ads at $142,361 to $391,492.

Keywords {🔍}

nature, drug, access, article, research, cell, development, cookies, content, open, privacy, discovery, cancer, data, reviews, anticancer, hait, breast, scientific, author, advertising, information, subscribe, challenges, william, oncology, institution, articles, evaluation, imaging, screening, reports, buy, permissions, optional, media, personal, parties, policy, journals, log, journal, comment, april, grand, cite, treatment, manufacture, herpositive, immunotoxin,

Topics {✒️}

nature portfolio permissions reprints privacy policy advertising nature social media anchorage-independent cell growth research advances anticancer drug development springerlink instant access author information authors drug discovery effectiveness personal data data protection permissions author declares competing financial interests privacy cell imaging author explore content subscription content lung cancer european economic area access heterogeneous tissue distribution institutional subscriptions read offered helpful comments senior vice president enaminone-grafted trithiocarbonate accepting optional cookies journals search log manage preferences biological screening content article hait development grand challenges william institution subscribe issue learn institution buy article purchase optional cookies choices article cite essential cookies cookies skip journal publish subscribe sign potential anticancer

Questions {❓}

• What are the key challenges in anticancer drug development, and how might they be addressed?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Anticancer drug development: the grand challenges
         description:Despite vast investment in oncology R&D, the translation of research advances into medicines that substantially improve the treatment of many cancers remains frustratingly slow. What are the key challenges in anticancer drug development, and how might they be addressed?
         datePublished:
         dateModified:
         pageStart:253
         pageEnd:254
         sameAs:https://doi.org/10.1038/nrd3144
         keywords:
            Drug development
            Drug regulation
            Biomedicine
            general
            Pharmacology/Toxicology
            Biotechnology
            Medicinal Chemistry
            Molecular Medicine
            Cancer Research
         image:
         isPartOf:
            name:Nature Reviews Drug Discovery
            issn:
               1474-1784
               1474-1776
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:William N. Hait
               affiliation:
                     name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
                     address:
                        name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Anticancer drug development: the grand challenges
      description:Despite vast investment in oncology R&D, the translation of research advances into medicines that substantially improve the treatment of many cancers remains frustratingly slow. What are the key challenges in anticancer drug development, and how might they be addressed?
      datePublished:
      dateModified:
      pageStart:253
      pageEnd:254
      sameAs:https://doi.org/10.1038/nrd3144
      keywords:
         Drug development
         Drug regulation
         Biomedicine
         general
         Pharmacology/Toxicology
         Biotechnology
         Medicinal Chemistry
         Molecular Medicine
         Cancer Research
      image:
      isPartOf:
         name:Nature Reviews Drug Discovery
         issn:
            1474-1784
            1474-1776
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:William N. Hait
            affiliation:
                  name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
                  address:
                     name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Reviews Drug Discovery
      issn:
         1474-1784
         1474-1776
      volumeNumber:9
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
      address:
         name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:William N. Hait
      affiliation:
            name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected]
            address:
               name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
               type:PostalAddress
            type:Organization
PostalAddress:
      name:William N. Hait, M.D., Ph.D., is Senior Vice President and Worldwide Head at Ortho Biotech Oncology Research and Development, 920 Route 202, Raritan, New Jersey 08869, USA. [email protected] ,
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(2)

• https://www.facebook.com/NatureReviews
• https://twitter.com/NatRevDrugDisc

External Links {🔗}(15)

• What is the earnings of https://doi.org/10.1186/s12934-023-02115-0?
• Get to know https://doi.org/10.1038/s41598-018-21950-5's earnings
• What are the earnings of https://doi.org/10.1038/s41598-017-13025-8?
• How much income does https://link.springer.com/article/10.1038/nrd3144?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle have?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=William%20N.%20Hait
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22William%20N.%20Hait%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much revenue does https://s100.copyright.com/AppDispatchServlet?title=Anticancer%20drug%20development%3A%20the%20grand%20challenges&author=William%20N.%20Hait&contentID=10.1038%2Fnrd3144©right=Springer%20Nature%20Limited&publication=1474-1776&publicationDate=2010-04&publisherName=SpringerNature&orderBeanReset=true bring in?
• What's the monthly money flow for https://citation-needed.springer.com/v2/references/10.1038/nrd3144?format=refman&flavour=citation?
• What's the total monthly financial gain of https://doi.org/10.1007/s00044-020-02535-2?
• How profitable is https://doi.org/10.1007/s10549-019-05331-8?
• What's the financial intake of https://doi.org/10.1038/nrd.2017.194?
• Find out how much https://www.protocols.io/ earns monthly
• How much money does https://www.natureindex.com/ generate?
• What's the monthly income of http://www.naturechina.com?
• What's the revenue for https://www.natureasia.com/ja-jp?

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Prism.js
• Zoom.js

Emails and Hosting {✉️}

Mail Servers:

• mxa-002c5801.gslb.pphosted.com
• mxb-002c5801.gslb.pphosted.com

Name Servers:

• pdns1.ultradns.net
• pdns2.ultradns.net
• pdns3.ultradns.org
• pdns4.ultradns.org
• pdns5.ultradns.info
• pdns6.ultradns.co.uk

CDN Services {📦}

• Crossref